5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: A nationwide survey

Most gastroenterologists are monitoring renal function once or twice a year in IBD patients on 5-ASA. Less than two thirds of them screen for renal failure before treatment initiation. MDRD is mainly used, but a wide range of parameters is evaluated.